20170406 Telix Logo.png
Telix Pharmaceuticals to Launch Japanese Renal Cancer Imaging Study
August 29, 2019 20:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and KYOTO, Japan, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the...
20170406 Telix Logo.png
Telixが日本で腎臓がん用画像診断薬の臨床治験を開始
August 29, 2019 20:00 ET | Telix Pharmaceuticals Limited
メルボルン, オーストラリア および京都, 日本, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals...
20170406 Telix Logo.png
Telix and Nihon Medi-Physics to Collaborate on Actinium Renal Cancer Therapeutics
November 28, 2018 18:17 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, KYOTO, Japan and TOKYO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused...
20170406 Telix Logo.png
テリックスと日本メジフィジックスが アクチニウム標識腎癌治療薬の開発を目指した技術提携契約を締結
November 28, 2018 18:17 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, KYOTO, Japan and TOKYO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited(本社:オーストラリア メルボルン、CEO:Dr. Christian...
20170406 Telix Logo.png
Telix and Nihon Medi-Physics to Collaborate on Renal Cancer Imaging for the Japanese Market MELBOURNE, Australia and KYOTO, Japan and TOKYO, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company...